Transplants of cells genetically modified to express neurotrophin-3 rescueaxotomized Clarke's nucleus neurons after spinal cord hemisection in adultrats
Bt. Himes et al., Transplants of cells genetically modified to express neurotrophin-3 rescueaxotomized Clarke's nucleus neurons after spinal cord hemisection in adultrats, J NEUROSC R, 65(6), 2001, pp. 549-564
To test the idea that genetically engineered cells can rescue axotomized ne
urons, we transplanted fibroblasts and immortalized neural stem cells (NSCs
) modified to express neurotrophic factors into the injured spinal cord. Th
e neurotrophin-3 (NT-3) or nerve growth factor (NGF) transgene was introduc
ed into these cells using recombinant retroviral vectors containing an inte
rnal ribosome entry site (IRES) sequence and the beta -galactosidase or alk
aline phosphatase reporter gene. Bioassay confirmed biological activity of
the secreted neurotrophic factors. Clarke's nucleus (CN) axons, which proje
ct to the rostra] spinal cord and cerebellum, were cut unilaterally in adul
t rats by T8 hemisection. Rats received transplants of fibroblasts or NSCs
genetically modified to express NT-3 or NGF and a reporter gene, only a rep
orter gene, or no transplant. Two months postoperatively, grafted cells sur
vived at the hemisection site. Grafted fibroblasts and NSCs expressed a rep
orter gene and immunoreactivity for the NGF or NT-3 transgene. Rats receivi
ng no transplant or a transplant expressing only a reporter gene showed a 3
0% loss of CN neurons in the L1 segment on the lesioned side. NGF-expressin
g transplants produced partial rescue compared with hemisection alone. Ther
e was no significant neuron loss in rats receiving grafts of either fibrobl
asts or NSCs engineered to express NT-3. We postulate that NT-3 mediates su
rvival of CN neurons through interaction with trkC receptors, which are exp
ressed on CN neurons. These results support the idea that NT-3 contributes
to long-term survival of axotomized CN neurons and show that genetically mo
dified cells rescue axotomized neurons as efficiently as fetal CNS transpla
nts. J. Neurosci. Res. 65:549-564, 2001. (C) 2001 Wiley-Liss, Inc.